Another batch of sales reps has sued Novo Nordisk ($NVO) for overtime. The would-be class action suit, which was filed by two reps, is seeking $70 million in overtime pay. Like so many other lawsuits–pending and otherwise–this one alleges a drugmaker misclassified its reps as exempt salaried workers when they should have been eligible for overtime. As Reuters reports, it’s… (more…)
